StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
KRYS

Krystal Biotech, Inc.

KRYS Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$312.57
-54.28 -14.80%

Key statistics

from XBRL data in SEC filings
Market cap
$9.25B
Revenue (TTM)
$440M
Net income (TTM)
$241M
EPS (TTM)
$7.97
P/E ratio
39.2
Dividend yield
Free cash flow
$189M
Cash
$428M
Total assets
$1.50B
Gross margin
52-week range
$131.00 – $382.54

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Results of operations (earnings release) Aug 3, 2026 10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Other events Jul 21, 2026 8-K Shareholder vote results May 20, 2026 8-K May 4, 2026 10-Q Quarter ended 2026-03-31 May 4, 2026 8-K Results of operations (earnings release) Feb 17, 2026 10-K Fiscal year ended 2025-12-31 Feb 17, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Regulation FD disclosure Jan 8, 2026 8-K Director or officer change Dec 23, 2025 8-K Results of operations (earnings release) Nov 3, 2025 10-Q Quarter ended 2025-09-30 Nov 3, 2025 8-K Other events Oct 22, 2025 8-K Results of operations (earnings release) Aug 4, 2025 10-Q Quarter ended 2025-06-30 Aug 4, 2025 8-K Regulation FD disclosure Jul 25, 2025 8-K Regulation FD disclosure Jul 24, 2025 8-K Regulation FD disclosure Jul 9, 2025 8-K Other events Jun 2, 2025 8-K Shareholder vote results May 19, 2025 8-K Regulation FD disclosure May 13, 2025 8-K Results of operations (earnings release) May 6, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Regulation FD disclosure May 6, 2025 8-K Regulation FD disclosure Apr 28, 2025 8-K Feb 28, 2025 8-K Regulation FD disclosure Feb 19, 2025 10-K Fiscal year ended 2024-12-31 Feb 19, 2025 8-K Regulation FD disclosure Dec 18, 2024 8-K Regulation FD disclosure Dec 12, 2024 10-Q Quarter ended 2024-09-30 Nov 4, 2024 8-K Results of operations (earnings release) Nov 4, 2024 8-K Regulation FD disclosure Aug 28, 2024 10-Q Quarter ended 2024-06-30 Aug 5, 2024 8-K Results of operations (earnings release) Aug 5, 2024 8-K Shareholder vote results May 21, 2024 8-K Regulation FD disclosure May 8, 2024 10-Q Quarter ended 2024-03-31 May 6, 2024 8-K Results of operations (earnings release) May 6, 2024